Iron oxide nanoparticles synthesized from plant materials have garnered considerable attention due to their environmentally friendly nature and wide-ranging applications in various fields. These NPs possess unique attributes, including biocompatibility, low toxicity, catalytic capabilities, and intricate reaction mechanisms, making them highly desirable for diverse biomedical uses. This study presents an innovative green synthesis approach for utilizing the fruit extract of Vicia faba (V. faba). The synthesized NPs underwent comprehensive characterization using advanced techniques such as Fourier-transform infrared spectroscopy (FTIR), UV-visible spectrophotometry, X-ray diffractometry (XRD), and Scanning Electron Microscope-Energy Dispersive X-ray (SEM-EDX). Notably, the V. faba fruit extract served as an effective reducing agent, facilitating the synthesis of Iron oxide nanoparticle (IONP) with well-defined structural and chemical properties. The size of Iron oxide nanoparticles falls between the range of 299.3-527.4 nm. Furthermore, the synthesized Iron oxide nanoparticles were evaluated for their antioxidant activity, revealing promising results against 2,2-diphenyl-1-picrylhydrazyl DPPH and 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) ABTS radicals. These findings highlight the significance of V. faba fruit extract in producing IONPs endowed with valuable bioactive properties, offering considerable potential for applications in biomedicine and beyond.
No takes yet. Share an insight, caveat, or question.
Prakash et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: